Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maha Ayyoub

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Clinical Immunology (Orlando, Fla.)|October 27, 2006
Epitope clustering in regions undergoing efficient proteasomal processing defines immunodominant CTL regions of a tumor antigenDanila Valmori, Frédéric Lévy, Emmanuelle Godefroy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Expression of synovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ T cellsDanila Valmori, Feng Qian, Maha Ayyoub, et al.
The Journal of Clinical Investigation|April 16, 2004
An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DRMaha Ayyoub, Charles S Hesdorffer, Monica Montes, et al.
Plos One|August 11, 2011
NY-ESO-1-specific circulating CD4+ T cells in ovarian cancer patients are prevalently T(H)1 type cells undetectable in the CD25+ FOXP3+ Treg compartmentNassima Redjimi, Karine Duperrier-Amouriaux, Isabelle Raimbaud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2026
Circulating transcriptome analysis finds gene signatures and immune cell activation and abundance predict response to immunotherapy in bladder cancerSandy Chevrier, Corentin Richard, Olivier Adotévi, et al.
Clinical Immunology (Orlando, Fla.)|December 15, 2004
Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2Maha Ayyoub, Andrea Merlo, Charles S Hesdorffer, et al.
Journal of Clinical Immunology|September 13, 2006
Ex-vivo analysis of CD8+ T cells infiltrating colorectal tumors identifies a major effector-memory subset with low perforin contentSheng-Wei Ye, Yu Wang, Danila Valmori, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2002
Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanomaMaha Ayyoub, Stefan Stevanovic, Ugur Sahin, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2006
Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancerPedro M S Alves, Nicole Lévy, Hanifa Bouzourene, et al.
European Journal of Immunology|September 5, 2002
Combinatorial peptide library-based identification of peptide ligands for tumor-reactive cytolytic T lymphocytes of unknown specificityVerena Rubio-Godoy, Maha Ayyoub, Valerie Dutoit, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Clinical Immunology (Orlando, Fla.)|October 27, 2006
Epitope clustering in regions undergoing efficient proteasomal processing defines immunodominant CTL regions of a tumor antigenDanila Valmori, Frédéric Lévy, Emmanuelle Godefroy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Expression of synovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ T cellsDanila Valmori, Feng Qian, Maha Ayyoub, et al.
The Journal of Clinical Investigation|April 16, 2004
An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DRMaha Ayyoub, Charles S Hesdorffer, Monica Montes, et al.
Plos One|August 11, 2011
NY-ESO-1-specific circulating CD4+ T cells in ovarian cancer patients are prevalently T(H)1 type cells undetectable in the CD25+ FOXP3+ Treg compartmentNassima Redjimi, Karine Duperrier-Amouriaux, Isabelle Raimbaud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2026
Circulating transcriptome analysis finds gene signatures and immune cell activation and abundance predict response to immunotherapy in bladder cancerSandy Chevrier, Corentin Richard, Olivier Adotévi, et al.
Clinical Immunology (Orlando, Fla.)|December 15, 2004
Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2Maha Ayyoub, Andrea Merlo, Charles S Hesdorffer, et al.
Journal of Clinical Immunology|September 13, 2006
Ex-vivo analysis of CD8+ T cells infiltrating colorectal tumors identifies a major effector-memory subset with low perforin contentSheng-Wei Ye, Yu Wang, Danila Valmori, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2002
Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanomaMaha Ayyoub, Stefan Stevanovic, Ugur Sahin, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2006
Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancerPedro M S Alves, Nicole Lévy, Hanifa Bouzourene, et al.
European Journal of Immunology|September 5, 2002
Combinatorial peptide library-based identification of peptide ligands for tumor-reactive cytolytic T lymphocytes of unknown specificityVerena Rubio-Godoy, Maha Ayyoub, Valerie Dutoit, et al.
Pageof 9